(DMID) NextGen COVID-19 Vaccines - Fill & Finish - A Platform Trial to Evaluate Next ...
Leidos Biomed seeks a US-based CDMO for Fill & Finish services of an mRNA-LNP vaccine for a Phase 1 trial, targeting Nov-Dec 2024. Subcontractor must confirm capability to meet timeline and adhere to cGMP. Questions due by Sep 20, 2024, and proposals by Sep 27, 2024.
Reference News
(DMID) NextGen COVID-19 Vaccines - Fill & Finish - A Platform Trial to Evaluate Next ...
Leidos Biomed seeks a US-based CDMO for Fill & Finish services of an mRNA-LNP vaccine for a Phase 1 trial, targeting Nov-Dec 2024. Subcontractor must confirm capability to meet timeline and adhere to cGMP. Questions due by Sep 20, 2024, and proposals by Sep 27, 2024.